Clinical trial

Evaluation of the Effect of Roflumilast in Hyperinflated COPD Patients Using Functional Respiratory Imaging

NCT02451540

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2015-09-01

PhasePHASE2

Study timeline

Study start (unknown)2015-09-01Date precision: month

Registry last updated2018-03-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

HRCT scanRADIATION

Placebo of RoflumilastDRUG

RoflumilastDRUG · verified · RxNorm: roflumilast

Sponsors & collaborators

FLUIDDA nvlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02451540 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.